Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

memantine

memantine
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Namenda XR CAPSULE, EXTENDED RELEASE, ORAL 7 mg, 14 mg, 21 mg, 28 mg    
Namenda TABLET, ORAL 5 mg, 10 mg      
VIEW MORE Central Nervous System Agents, Miscellaneous
CLASS
289200
Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

memantine (Namenda XR)

  • 7 mg extended release capsule oral Daily
  • 14 mg extended release capsule oral Daily
  • 21 mg extended release capsule oral Daily
  • 28 mg extended release capsule oral Daily

 memantine (Namenda)

  • 5 mg tablet oral Daily                               
  • 10 mg tablet oral Daily                                  
  • THREE 5 mg tablets oral Daily (Total: 15 mg)
  • 20 mg tablet oral Daily OR 10 mg tablet oral BID

 

Reviewed: August 28, 2013 (NAMENDA XR)

Last updated: Dec. 26, 2017






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved